Attribution of Invasive Group A Streptococcal Infections (iGAS) to Predisposing Viral Infections, the Netherlands, 2010 to 2023

Overview

Journal Euro Surveill

Specialty Infectious Diseases

Date 2024 Oct 4

PMID 39364598

Authors

Brechje de Gier

Jan van de Kassteele

Liselotte van Asten

Annelot F Schoffelen

Mariette Hooiveld

Margreet Jm Te Wierik

Nina M Van Sorge

Hester E de Melker

Affiliations

Soon will be listed here.

Abstract

BackgroundAfter most COVID-19 pandemic control measures were lifted in 2022, many infectious diseases re-emerged. An increase in invasive group A streptococcal (iGAS) infections among adults and young children was reported by several countries. Viral infections including influenza and varicella, known risk factors for iGAS infection, also increased.AimTo estimate the proportion of GAS skin and soft tissue infections (SSTI) and pneumonia/sepsis in children (≤ 5 years) attributable to varicella, and the proportion of GAS pneumonia/sepsis in children and adults attributable to potentially predisposing respiratory viruses influenza A and B, RSV, hMPV and SARS-CoV-2 in the Netherlands.MethodsWe performed time series regression using weekly data on respiratory viruses, varicella and non-invasive GAS infections and GAS isolates cultured from blood, lower airways, skin, pus and wounds, from January 2010 to March 2023.ResultsIn 2010-19, 50% (95% CI: 36-64) of GAS SSTI in children were attributable to varicella. Between January 2022 and March 2023, 34% (95% CI: 24-43) of GAS SSTI cases were attributable to varicella. Of iGAS pneumonia/sepsis between January 2022 and March 2023, 34% (95% CI: 20-49) and 25% (95% CI: 18-32) was attributable to respiratory virus infections in children and adults, respectively, with the largest contributor (17%) being influenza A.ConclusionsPredisposing viral infections likely contributed to, but cannot fully explain, the observed iGAS increase among children and adults in 2022-23 in the Netherlands. Public health measures to control viral infections, such as vaccination against varicella or influenza, might reduce the iGAS disease burden.

References

Davies P, Russell C, Morgan A, Taori S, Lindsay D, Ure R . Increase of Severe Pulmonary Infections in Adults Caused by M1 Streptococcus pyogenes, Central Scotland, UK. Emerg Infect Dis. 2023; 29(8):1638-1642. PMC: 10370863. DOI: 10.3201/eid2908.230569. View

Hasin O, Hazan G, Rokney A, Dayan R, Sagi O, Ben-Shimol S . Invasive Group A Streptococcus Infection in Children in Southern Israel Before and After the Introduction of Varicella Vaccine. J Pediatric Infect Dis Soc. 2019; 9(2):236-239. DOI: 10.1093/jpids/piz013. View

Imohl M, van der Linden M, Reinert R, Ritter K . Invasive group A streptococcal disease and association with varicella in Germany, 1996-2009. FEMS Immunol Med Microbiol. 2011; 62(1):101-9. DOI: 10.1111/j.1574-695X.2011.00788.x. View

Guy R, Henderson K, Coelho J, Hughes H, Mason E, Gerver S . Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill. 2023; 28(1). PMC: 9817207. DOI: 10.2807/1560-7917.ES.2023.28.1.2200942. View

Cobo-Vazquez E, Aguilera-Alonso D, Carrasco-Colom J, Calvo C, Saavedra-Lozano J . Increasing incidence and severity of invasive Group A streptococcal disease in Spanish children in 2019-2022. Lancet Reg Health Eur. 2023; 27:100597. PMC: 9989682. DOI: 10.1016/j.lanepe.2023.100597. View

Rumke L, de Gier B, Vestjens S, van der Ende A, Van Sorge N, Vlaminckx B . Dominance of M1 clade among Dutch M1 Streptococcus pyogenes. Lancet Infect Dis. 2020; 20(5):539-540. DOI: 10.1016/S1473-3099(20)30278-4. View

Gouveia C, Bajanca-Lavado M, Mamede R, Carvalho A, Rodrigues F, Melo-Cristino J . Sustained increase of paediatric invasive infections dominated by M1 and diverse 12 isolates, Portugal, September 2022 to May 2023. Euro Surveill. 2023; 28(36). PMC: 10486195. DOI: 10.2807/1560-7917.ES.2023.28.36.2300427. View

Laupland K, Davies H, Low D, Schwartz B, Green K, McGeer A . Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics. 2000; 105(5):E60. DOI: 10.1542/peds.105.5.e60. View

Davies M, Keller N, Brouwer S, Jespersen M, Cork A, Hayes A . Detection of Streptococcus pyogenes M1 in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA. Nat Commun. 2023; 14(1):1051. PMC: 9951164. DOI: 10.1038/s41467-023-36717-4. View

10.

Gasparrini A . Distributed Lag Linear and Non-Linear Models in R: The Package dlnm. J Stat Softw. 2011; 43(8):1-20. PMC: 3191524. View

11.

Herrera A, Potts R, Huber V, Chaussee M . Influenza enhances host susceptibility to non-pulmonary invasive infections. Virulence. 2023; 14(1):2265063. PMC: 10566429. DOI: 10.1080/21505594.2023.2265063. View

12.

Altorf-van der Kuil W, Schoffelen A, De Greeff S, Thijsen S, Alblas H, Notermans D . National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands. Euro Surveill. 2017; 22(46). PMC: 5718398. DOI: 10.2807/1560-7917.ES.2017.22.46.17-00062. View

13.

Frere J, Bidet P, Tapiero B, Rallu F, Minodier P, Bonacorsi S . Clinical and Microbiological Characteristics of Invasive Group A Streptococcal Infections Before and After Implementation of a Universal Varicella Vaccine Program. Clin Infect Dis. 2015; 62(1):75-7. DOI: 10.1093/cid/civ793. View

14.

van Boven M, Hetebrij W, Swart A, Nagelkerke E, van der Beek R, Stouten S . Patterns of SARS-CoV-2 circulation revealed by a nationwide sewage surveillance programme, the Netherlands, August 2020 to February 2022. Euro Surveill. 2023; 28(25). PMC: 10288829. DOI: 10.2807/1560-7917.ES.2023.28.25.2200700. View

15.

Holdstock V, Twynam-Perkins J, Bradnock T, Dickson E, Harvey-Wood K, Kalima P . National case series of group A streptococcus pleural empyema in children: clinical and microbiological features. Lancet Infect Dis. 2023; 23(2):154-156. DOI: 10.1016/S1473-3099(23)00008-7. View

16.

van Kempen E, Bruijning-Verhagen P, Borensztajn D, Vermont C, Quaak M, Janson J . Increase in Invasive Group a Streptococcal Infections in Children in the Netherlands, A Survey Among 7 Hospitals in 2022. Pediatr Infect Dis J. 2023; 42(4):e122-e124. DOI: 10.1097/INF.0000000000003810. View

17.

Lynskey N, Jauneikaite E, Li H, Zhi X, Turner C, Mosavie M . Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis. 2019; 19(11):1209-1218. PMC: 6838661. DOI: 10.1016/S1473-3099(19)30446-3. View

18.

Nygaard U, Hartling U, Munkstrup C, Nielsen A, Dungu K, Schmidt L . Invasive group A streptococcal infections in children and adolescents in Denmark during 2022-23 compared with 2016-17 to 2021-22: a nationwide, multicentre, population-based cohort study. Lancet Child Adolesc Health. 2023; 8(2):112-121. DOI: 10.1016/S2352-4642(23)00295-X. View

19.

de Gier B, Vlaminckx B, Woudt S, Van Sorge N, van Asten L . Associations between common respiratory viruses and invasive group A streptococcal infection: A time-series analysis. Influenza Other Respir Viruses. 2019; 13(5):453-458. PMC: 6692538. DOI: 10.1111/irv.12658. View

20.

Herrera A, Huber V, Chaussee M . The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections. Front Microbiol. 2016; 7:342. PMC: 4800185. DOI: 10.3389/fmicb.2016.00342. View